Stamm, Luisa : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (36)
Les plus populaires
Liste
- Liste
- Tableau

1

Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients

Agarwal, Kosh, Castells, Lluís, Müllhaupt, Beat, Rosenberg, William M.C., McNabb, Brian, Arterburn, Sarah, Camus, Gregory, McNally, John, Stamm, Luisa M., Brainard, Diana M., Subramanian, G. Mani, Mar

Journal:

Journal of Hepatology

Année:

2018

Langue:

english

Fichier:

PDF, 770 KB

english, 2018

2

Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers

Mogalian, Erik, Stamm, Luisa M, Osinusi, Anu, Brainard, Diana M, Shen, Gong, Ling, Kah Hiing John, Mathias, Anita

Journal:

Clinical Infectious Diseases

Année:

2018

Langue:

english

Fichier:

PDF, 487 KB

english, 2018

3

Sofosbuvir/Velpatasvir for Patients with Chronic Genotype 3 HCV Infection with Compensated Cirrhosis: Response to EASL Recommendations on Treatment of Hepatitis C 2018

Stamm, Luisa M., Brainard, Diana M., McHutchison, John G.

Journal:

Journal of Hepatology

Année:

2018

Langue:

english

Fichier:

PDF, 460 KB

english, 2018

4

STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis

Luisa M. Stamm, Anjali A. Satoskar, Sudip K. Ghosh, John R. David, Abhay R. Satoskar

Journal:

European Journal of Immunology

Année:

1999

Langue:

english

Fichier:

PDF, 163 KB

english, 1999

5

Mycobacterium marinum: the generalization and specialization of a pathogenic mycobacterium

Luisa M. Stamm, Eric J. Brown

Journal:

Microbes and Infection

Année:

2004

Langue:

english

Fichier:

PDF, 2.61 MB

english, 2004

6

Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection

Abhay R. Satoskar, Jennifer Elizondo, Gina M. Monteforte, Luisa M. Stamm, Horst Bluethmann, Paula Katavolos, Sam R. Telford III

Journal:

FEMS Microbiology Letters

Année:

2000

Langue:

english

Fichier:

PDF, 713 KB

english, 2000

7

Caging Targets for Destruction

Luisa M. Stamm, Danielle M. Heller, Marcia B. Goldberg

Journal:

Cell Host & Microbe

Année:

2010

Langue:

english

Fichier:

PDF, 225 KB

english, 2010

8

Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection

Abhay R. Satoskar, Jennifer Elizondo, Gina M. Monteforte, Luisa M. Stamm, Horst Bluethmann, Paula Katavolos, Sam R. Telford III

Journal:

FEMS Microbiology Letters

Année:

2000

Langue:

english

Fichier:

PDF, 715 KB

english, 2000

9

Acute Nonrheumatic Streptococcal Myocarditis: STEMI Mimic in Young Adults

Upadhyay, Gaurav A., Gainor, Justin F., Stamm, Luisa M., Weinberg, Arnold N., Dec, G. William, Ruskin, Jeremy N.

Journal:

The American Journal of Medicine

Année:

2012

Langue:

english

Fichier:

PDF, 640 KB

english, 2012

10

650 Integrated Safety Analysis of Sofosbuvir-Based HCV Treatment Regimens From Phase 3 Studies

Gordon, Stuart C., Towner, William, Aggarwal, Avanish, Ma, Julie, McNally, John, Stamm, Luisa M., Brainard, Diana M., Symonds, William T., McHutchison, John G., Tashima, Karen, Afdhal, Nezam H.

Journal:

Gastroenterology

Année:

2014

Langue:

english

Fichier:

PDF, 409 KB

english, 2014

11

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

Yoshida, Eric M., Sulkowski, Mark S., Gane, Edward J., Herring, Robert W., Ratziu, Vlad, Ding, Xiao, Wang, Jing, Chuang, Shu-Min, Ma, Julie, McNally, John, Stamm, Luisa M., Brainard, Diana M., Symonds

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 987 KB

english, 2015

12

Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin

Hedskog, Charlotte, Doehle, Brian, Chodavarapu, Krishna, Gontcharova, Viktoria, Crespo Garcia, Javier, De Knegt, Robert, Drenth, Joost P.H, McHutchison, John G., Brainard, Diana, Stamm, Luisa M., Mill

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.03 MB

english, 2015

13

Dysregulation of Distal Cholesterol Biosynthesis in Association with Relapse and Advanced Disease in CHC Genotype 2 and 3 Treated with Sofosbuvir and Ribavirin

Younossi, Zobair M., Stepanova, Maria, Estep, Michael, Negro, Francesco, Clark, Paul J., Hunt, Sharon, Song, Qinghua, Paulson, Matthew, Stamm, Luisa M., Brainard, Diana M., Mani Subramanian, G., McHut

Journal:

Journal of Hepatology

Année:

2015

Langue:

english

Fichier:

PDF, 1.01 MB

english, 2015

14

Successful Retreatment of HCV in Patients Coinfected with HIV Who Failed 12 Weeks of Ledipasvir/Sofosbuvir

Cooper, Curtis, Naggie, Susanna, Saag, Michael, Yang, Jenny C., Stamm, Luisa M., Dvory-Sobol, Hadas, Han, LingLing, Pang, Phillip S., McHutchison, John G., Dieterich, Douglas, Sulkowski, Mark

Journal:

Clinical Infectious Diseases

Année:

2016

Langue:

english

Fichier:

PDF, 882 KB

english, 2016

15

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naïve or Previously Treated Patients with HCV Genotype 1 or 3 Infections

Gane, Edward J., Schwabe, Christian, Hyland, Robert H., Yang, Yin, Svarovskaia, Evguenia, Stamm, Luisa M., Brainard, Diana M., McHutchison, John G., Stedman, Catherine A.

Journal:

Gastroenterology

Année:

2016

Langue:

english

Fichier:

PDF, 460 KB

english, 2016

16

Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection

Carlin, Aaron F., Aristizabal, Paula, Song, Qinghua, Wang, Huan, Paulson, Matthew S., Stamm, Luisa M., Schooley, Robert T., Wyles, David L.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 718 KB

english, 2015

17

Intermediate filaments enable pathogen docking to trigger type 3 effector translocation

Russo, Brian C., Stamm, Luisa M., Raaben, Matthijs, Kim, Caleb M., Kahoud, Emily, Robinson, Lindsey R., Bose, Sayantan, Queiroz, Ana L., Herrera, Bobby Brooke, Baxt, Leigh A., Mor-Vaknin, Nirit, Fu, Y

Journal:

Nature Microbiology

Année:

2016

Langue:

english

Fichier:

PDF, 3.32 MB

english, 2016

18

Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei

David, John R, Stamm, Luisa M, Bezerra, Haroldo Sergio, Souza, Raimundo Nonato, Killick-Kendrick, Robert, Lima, José Wellington Oliveira

Journal:

Memórias do Instituto Oswaldo Cruz

Année:

2001

Langue:

english

Fichier:

PDF, 93 KB

english, 2001

19

Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection

Gane, Edward J., Hyland, Robert H., Yang, Yin, Svarovskaia, Evguenia, Stamm, Luisa M., Brainard, Diana M., McHutchison, John G., Stedman, Catherine A.M.

Journal:

Gastroenterology

Année:

2017

Langue:

english

Fichier:

PDF, 377 KB

english, 2017

20

Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in DAA-experienced patients with genotype 1 HCV

Lawitz, Eric, Poordad, Fred, Wells, Jennifer, Hyland, Robert H., Yang, Yin, Dvory-Sobol, Hadas, Stamm, Luisa M., Brainard, Diana M., McHutchison, John G., Landaverde, Carmen, Gutierrez, Julio

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 927 KB

english, 2017

21

The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease

Simon, Tracey G, Kim, Arthur Y, Stamm, Luisa M, Liu, Lin, Mo, Hongmei, Doehle, Brian, Pang, Phillip S, Brainard, Diana M, McHutchison, John G, Gustafson, Jenna, Lauer, Georg M, Chung, Raymond T

Journal:

Antiviral Therapy

Année:

2015

Langue:

english

Fichier:

PDF, 557 KB

english, 2015

22

Characterization of HCV resistance from a 3-day monotherapy study of voxilaprevir, a novel pangenotypic NS3/4A protease inhibitor

Lawitz, Eric, Yang, Jenny C, Stamm, Luisa M, Taylor, James G, Cheng, Guofeng, Brainard, Diana M, Miller, Michael D, Mo, Hongmei, Dvory-Sobol, Hadas

Journal:

Antiviral Therapy

Année:

2017

Langue:

english

Fichier:

PDF, 354 KB

english, 2017

23

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

Grebely, Jason, Feld, Jordan J, Wyles, David, Sulkowski, Mark, Ni, Liyun, Llewellyn, Joe, Mir, Heshaam M, Sajed, Nika, Stamm, Luisa M, Hyland, Robert H, McNally, John, Brainard, Diana M, Jacobson, Ira

Journal:

Open Forum Infectious Diseases

Année:

2018

Langue:

english

Fichier:

PDF, 142 KB

english, 2018

24

Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1

Bourlière, Marc, Gordon, Stuart C, Schiff, Eugene R, Tran, Tram T, Ravendhran, Natarajan, Landis, Charles S, Hyland, Robert H, Stamm, Luisa M, Zhang, Jie, Dvory-Sobol, Hadas, Subramanian, G Mani, Brai

Journal:

The Lancet Gastroenterology & Hepatology

Année:

2018

Langue:

english

Fichier:

PDF, 99 KB

english, 2018

25

Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV–Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial

Kleinstein, Sarah E, Shea, Patrick R, Stamm, Luisa M, Sulkowski, Mark, Goldstein, David B, Naggie, Susanna

Journal:

Clinical Infectious Diseases

Année:

2018

Langue:

english

Fichier:

PDF, 270 KB

english, 2018

26

Identification of a Novel Hepatitis C Virus Genotype from Punjab, India - Expanding Classification of Hepatitis C Virus into 8 Genotypes

Borgia, Sergio M, Hedskog, Charlotte, Parhy, Bandita, Hyland, Robert H, Stamm, Luisa M, Brainard, Diana M, Subramanian, Mani G, McHutchison, John G, Mo, Hongmei, Svarovskaia, Evguenia, Shafran, Stephe

Journal:

The Journal of Infectious Diseases

Année:

2018

Langue:

english

Fichier:

PDF, 630 KB

english, 2018

27

717 - SOF/VEL/VOX for 12 Weeks is a Safe and Effective Salvage Regimen for NS5A Inhibitor-Experienced Patients with Genotype 1-6 HCV Infection: an Integrated Analysis of Phase 2 and Phase 3 Studies

Lawitz, Eric, Manns, Michael, Bourliere, Marc, Cheinquer, Nelson, Stamm, Luisa, Hyland, Robert H., Ni, Liyun, Dvory-Sobol, Hadas, Brainard, Diana, Subramanian, Mani, Gane, Edward

Journal:

Gastroenterology

Année:

2018

Langue:

english

Fichier:

PDF, 540 KB

english, 2018

28

Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir-Containing Regimen: Results from a Retreatment Study

Ruane, Peter, Strasser, Simone I., Gane, Edward J., Hyland, Robert H., Shao, Jiang, Dvory-Sobol, Hadas, Tran, Tram, Stamm, Luisa M., Brainard, Diana M., Nyberg, Lisa, Shafran, Stephen

Journal:

Journal of Viral Hepatitis

Année:

2019

Fichier:

PDF, 363 KB

2019

29

Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India

Sood, Ajit, Duseja, Ajay, Kabrawala, Mayank, Amrose, Pradeep, Goswami, Bhadadev, Chowdhury, Abhijit, Sarin, Shiv Kumar, Koshy, Abraham, Hyland, Robert H., Lu, Sophia, Camus, Gregory, Stamm, Luisa M.,

Journal:

Hepatology International

Année:

2019

Langue:

english

Fichier:

PDF, 370 KB

english, 2019

30

Comparison of Efficacy of Sofosbuvir plus Ribavirin in Chinese Patients with Genotype 3a or 3b HCV Infection

Huang, Rui, Rao, Huiying, Xie, Qing, Gao, Zhiliang, Li, Wu, Jiang, Deyuan, Mo, Hongmei, Massetto, Benedetta, Stamm, Luisa M., Brainard, Diana M., Wei, Lai

Journal:

Journal of Medical Virology

Année:

2019

Langue:

english

Fichier:

PDF, 269 KB

english, 2019

31

Sofosbuvir/Velpatasvir Plus GS-9857 (100 Milligrams) for 6, 8, or 12 Weeks in Genotype 1-6 Hepatitis C Virus (HCV)-Infected Patients: An Integrated Analysis of Safety and Efficacy From Two Phase 2 Studies

Nahass, Ronald, Lawitz, Eric, Jacobson, Ira M., Kwo, Paul, Ngyuyen, Mindie, Yang, Jenny C., Stamm, Luisa, Lu, Sophia, Sobol, Hadas, Naik, Sarjita, Llewellyn, Joe, Brainard, Diana, McHutchison, John G.

Journal:

Open Forum Infectious Diseases

Année:

2016

Langue:

english

Fichier:

PDF, 110 KB

english, 2016

32

Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection

Agarwal, Kosh, Niu, Junqi, Ding, Yanhua, Gane, Edward, Nguyen, Tuan, Alves, Katia, Evanchick, Marc, Zayed, Hany, Huang, Qi, Knox, Steven, Stamm, Luisa, Colonno, Richard, Hassanein, Tarek, Kim, Dong Jo

Journal:

Journal of Hepatology

Année:

2020

Fichier:

PDF, 59 KB

2020

33

P16âSOF/VEL/VOX for 8 or 12 weeks results in high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3 AND POLARIS-4 studies

Roberts, Stuart K., Cooper, Curtis L., Lawitz, Eric, Rajender Reddy, K., Thompson, Alex J., Zeuzem, Stefan, Jacobson, Ira M., Ruane, Peter, Hyland, Robert H., Stamm, Luisa M., Han, Lingling, Brainard,

Journal:

Journal of Virus Eradication

Année:

2017

Fichier:

PDF, 50 KB

2017

34

[BMJ Publishing Group Ltd and British Society of Gastroenterology International Digestive Disease Forum (IDDF) 2018, Best Abstracts, Hong Kong, 9â10 June 2018 - ()] Clinical Hepatology - IDDF2018-ABS-0113âThe safety and tolerability of sof/vel/vox for 8 or 12 weeks in >1,000 patients treated in the polaris-1, polaris-2, polaris-3, and polaris-4 studies: an integrated analysis

Manns, Michael P, Gane, Edward, Willems, Bernard E, Roberts, Stuart K, Flamm, Steven, Bourliere, Marc, Asselah, Tarik, Alric, Laurent, Hyland, Robert H, Stamm, Luisa M, Huang, KC, Brainard, Diana M, Y

Fichier:

PDF, 56 KB

35

[BMJ Publishing Group Ltd and British Society of Gastroenterology International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8â9 June 2019 - ()] Clinical Hepatology - IDDF2019-ABS-0134âSofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies

Esteban, Rafael, Agarwal, Kosh, Calleja, Jose Luis, Dufour, Jean-Francois, Flamm, Steven, Gordon, Stuart, Stamm, Luisa, Ni, Liyun, Brainard, Diana, Sze Man Yip, Christina, Kowdley, Kris, Cooper, Curti

Année:

2019

Fichier:

PDF, 53 KB

2019

36

[BMJ Publishing Group Ltd and British Society of Gastroenterology International Digestive Disease Forum (IDDF) 2018, Hong Kong, 9â10 June 2018 - ()] Clinical Hepatology - IDDF2018-ABS-0114âSOF/VEL/VOX results in high SVR12 rates when administered for 12 weeks in DAA-experienced patients or for 8 weeks in daa-naive patients: an integrated analysis of the polaris-1, polaris-2, polaris-3 and polaris-4 studies

Roberts, Stuart K, Cooper, Curtis L, Lawitz, Eric, Rajender Reddy, K, Thompson, Alex J, Zeuzem, Stefan, Jacobson, Ira M, Ruane, Peter, Hyland, Robert H, Stamm, Luisa M, Han, Lingling, Brainard, Diana

Année:

2018

Fichier:

PDF, 67 KB

2018